MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prime Medicine (PRME) Earnings Date & Reports
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression... Show more
A.I. Advisor
published Earnings
PRME is expected to report earnings to fall 4.17% to -23 cents per share on November 06
Q3'26
Est.
$-0.23
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.21
Q3'25
Beat
by $0.11
The last earnings report on August 06 showed earnings per share of -23 cents, beating the estimate of -36 cents. With 1.60M shares outstanding, the current market capitalization sits at 691.05M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
60 First Street
Phone
+1 617 465-0013
Employees
146
Web
https://www.primemedicine.com